• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ErbB2的内吞下调是由其C末端的裂解所刺激的。

Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.

作者信息

Lerdrup Mads, Bruun Silas, Grandal Michael V, Roepstorff Kirstine, Kristensen Malene M, Hommelgaard Anette M, van Deurs Bo

机构信息

Department of Cellular and Molecular Medicine, University of Copenhagen, The Panum Institute, DK-2200 Copenhagen N, Denmark.

出版信息

Mol Biol Cell. 2007 Sep;18(9):3656-66. doi: 10.1091/mbc.e07-01-0025. Epub 2007 Jul 11.

DOI:10.1091/mbc.e07-01-0025
PMID:17626164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1951740/
Abstract

High ErbB2 levels are associated with cancer, and impaired endocytosis of ErbB2 could contribute to its overexpression. Therefore, knowledge about the mechanisms underlying endocytic down-regulation of ErbB2 is warranted. The C-terminus of ErbB2 can be cleaved after various stimuli, and after inhibition of HSP90 with geldanamycin this cleavage is accompanied by proteasome-dependent endocytosis of ErbB2. However, it is unknown whether C-terminal cleavage is linked to endocytosis. To study ErbB2 cleavage and endocytic trafficking, we fused yellow fluorescent protein (YFP) and cyan fluorescent protein (CFP) to the N- and C-terminus of ErbB2, respectively (YFP-ErbB2-CFP). After geldanamycin stimulation YFP-ErbB2-CFP became cleaved in nonapoptotic cells in a proteasome-dependent manner, and a markedly larger relative amount of cleaved YFP-ErbB2-CFP was observed in early endosomes than in the plasma membrane. Furthermore, cleavage took place at the plasma membrane, and cleaved ErbB2 was internalized and degraded far more efficiently than full-length ErbB2. Concordantly, a C-terminally truncated ErbB2 was also readily endocytosed and degraded in lysosomes compared with full-length ErbB2. Altogether, we suggest that geldanamycin leads to C-terminal cleavage of ErbB2, which releases the receptor from a retention mechanism and causes endocytosis and lysosomal degradation of ErbB2.

摘要

ErbB2水平升高与癌症相关,而ErbB2内吞作用受损可能导致其过度表达。因此,有必要了解ErbB2内吞下调的潜在机制。在各种刺激后,ErbB2的C末端可被切割,用格尔德霉素抑制热休克蛋白90(HSP90)后,这种切割伴随着ErbB2的蛋白酶体依赖性内吞作用。然而,C末端切割是否与内吞作用有关尚不清楚。为了研究ErbB2的切割和内吞运输,我们分别将黄色荧光蛋白(YFP)和青色荧光蛋白(CFP)融合到ErbB2的N末端和C末端(YFP-ErbB2-CFP)。在格尔德霉素刺激后,YFP-ErbB2-CFP在非凋亡细胞中以蛋白酶体依赖性方式被切割,并且在早期内体中观察到的切割YFP-ErbB2-CFP的相对量明显大于质膜中的相对量。此外,切割发生在质膜上,与全长ErbB2相比,切割后的ErbB2更有效地被内化和降解。一致地,与全长ErbB2相比,C末端截短的ErbB2也很容易被内吞并在溶酶体中降解。总之,我们认为格尔德霉素导致ErbB2的C末端切割,从而使受体从保留机制中释放出来,并导致ErbB2的内吞作用和溶酶体降解。

相似文献

1
Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.ErbB2的内吞下调是由其C末端的裂解所刺激的。
Mol Biol Cell. 2007 Sep;18(9):3656-66. doi: 10.1091/mbc.e07-01-0025. Epub 2007 Jul 11.
2
Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes.预先泛素化的嵌合 ErbB2 持续内吞并随后在溶酶体中降解。
Exp Cell Res. 2013 Feb 1;319(3):32-45. doi: 10.1016/j.yexcr.2012.10.010. Epub 2012 Nov 2.
3
Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.乳腺癌细胞中HSP90调控的ERBB2降解多步骤过程的鉴定
Oncotarget. 2016 Dec 20;7(51):85411-85429. doi: 10.18632/oncotarget.13392.
4
Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.格尔德霉素以蛋白酶体依赖的方式刺激表皮生长因子受体2(ErbB2)的内化。
J Cell Sci. 2006 Jan 1;119(Pt 1):85-95. doi: 10.1242/jcs.02707. Epub 2005 Dec 13.
5
Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent.格尔德霉素诱导的表皮生长因子受体2(ErbB2)从质膜的下调是网格蛋白依赖性的,但不依赖蛋白酶体活性。
Mol Cancer Res. 2008 Mar;6(3):491-500. doi: 10.1158/1541-7786.MCR-07-0191.
6
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.去泛素化酶 USP2 通过拮抗内吞降解来维持 ErbB2 的丰度,是 ErbB2 阳性乳腺癌的治疗靶点。
Cell Death Differ. 2020 Sep;27(9):2710-2725. doi: 10.1038/s41418-020-0538-8. Epub 2020 Apr 23.
7
Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.格尔德霉素处理的人乳腺癌细胞中ErbB2的网格蛋白非依赖性内吞作用
J Cell Sci. 2008 Oct 1;121(Pt 19):3155-66. doi: 10.1242/jcs.020404. Epub 2008 Sep 2.
8
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.表皮生长因子受体2(ErbB2)的内吞作用与分选以及癌症治疗药物曲妥珠单抗和格尔德霉素的作用位点
Mol Biol Cell. 2004 Dec;15(12):5268-82. doi: 10.1091/mbc.e04-07-0591. Epub 2004 Sep 22.
9
The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.HSP90 抑制剂格尔德霉素扰乱内体结构,并驱动循环 ErbB2 和转铁蛋白到修饰的 MVB/溶酶体隔室。
Mol Biol Cell. 2013 Jan;24(2):129-44. doi: 10.1091/mbc.E12-04-0282. Epub 2012 Nov 14.
10
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.表皮生长因子受体或ErbB3的表达促进格尔德霉素诱导的ErbB2下调。
Mol Cancer Res. 2009 Feb;7(2):275-84. doi: 10.1158/1541-7786.MCR-07-2183. Epub 2009 Feb 10.

引用本文的文献

1
Innately Fluorescent Tetravalent Cytotoxic Conjugate TetraF-vcMMAE Engages Aggregation-Dependent Endocytosis of HER2 for Enhanced Intracellular Drug Delivery.具有内在荧光的四价细胞毒性缀合物TetraF-vcMMAE通过HER2的聚集依赖性内吞作用实现增强的细胞内药物递送。
J Med Chem. 2025 Jul 10;68(13):13872-13886. doi: 10.1021/acs.jmedchem.5c00782. Epub 2025 Jun 29.
2
EGFR trafficking: effect of dimerization, dynamics, and mutation.表皮生长因子受体(EGFR)的转运:二聚化、动力学及突变的影响
Front Oncol. 2023 Sep 11;13:1258371. doi: 10.3389/fonc.2023.1258371. eCollection 2023.
3
Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2.不可逆酪氨酸激酶抑制剂可诱导表皮生长因子受体2(ErbB2)的内吞作用及下调。
Biochem Biophys Rep. 2023 Feb 6;34:101436. doi: 10.1016/j.bbrep.2023.101436. eCollection 2023 Jul.
4
Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.扩展 Erbbs 蛋白 C 末端尾部的紊乱-功能范式。
Biomolecules. 2021 Nov 14;11(11):1690. doi: 10.3390/biom11111690.
5
Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development.内吞作用机制对目前已获批抗体药物偶联物(ADC)所靶向受体的影响——未来ADC研发的必要性
Pharmaceuticals (Basel). 2021 Jul 15;14(7):674. doi: 10.3390/ph14070674.
6
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.去泛素化酶 USP2 通过拮抗内吞降解来维持 ErbB2 的丰度,是 ErbB2 阳性乳腺癌的治疗靶点。
Cell Death Differ. 2020 Sep;27(9):2710-2725. doi: 10.1038/s41418-020-0538-8. Epub 2020 Apr 23.
7
Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.蛋白酶体26S亚基非ATP酶3(PSMD3)通过稳定HER2防止其降解来调控乳腺癌。
Cancers (Basel). 2019 Apr 12;11(4):527. doi: 10.3390/cancers11040527.
8
MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.MEK 抑制剂通过抑制 ERK 介导的 HER2 磷酸化的负反馈 Thr701 位点,诱导 Akt 激活和耐药性。
Mol Oncol. 2017 Sep;11(9):1273-1287. doi: 10.1002/1878-0261.12102. Epub 2017 Jul 19.
9
HER2 signaling regulates HER2 localization and membrane retention.HER2信号传导调节HER2的定位和膜保留。
PLoS One. 2017 Apr 3;12(4):e0174849. doi: 10.1371/journal.pone.0174849. eCollection 2017.
10
Septins: Regulators of Protein Stability.Septin蛋白:蛋白质稳定性的调节因子
Front Cell Dev Biol. 2016 Dec 20;4:143. doi: 10.3389/fcell.2016.00143. eCollection 2016.

本文引用的文献

1
Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification.蛋白激酶Cα决定了HER2蛋白过表达但无基因扩增的乳腺癌细胞中HER2的命运。
Cancer Res. 2007 Jun 1;67(11):5308-17. doi: 10.1158/0008-5472.CAN-06-3936.
2
Molecular chaperones and protein kinase quality control.分子伴侣与蛋白激酶质量控制
Trends Cell Biol. 2007 Feb;17(2):87-92. doi: 10.1016/j.tcb.2006.12.002. Epub 2006 Dec 20.
3
The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.20S蛋白酶体以不依赖翻译的方式将NF-κB1 p105加工成p50。
EMBO J. 2006 May 3;25(9):1945-56. doi: 10.1038/sj.emboj.7601081. Epub 2006 Apr 13.
4
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.抗体诱导的胞外域脱落介导肝细胞生长因子受体下调并阻碍其生物学活性。
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5090-5. doi: 10.1073/pnas.0508156103. Epub 2006 Mar 17.
5
Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments.肿瘤细胞通过产生透明质酸片段来增强自身的CD44裂解和运动能力。
J Biol Chem. 2006 Mar 3;281(9):5861-8. doi: 10.1074/jbc.M506740200. Epub 2005 Dec 29.
6
Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.格尔德霉素以蛋白酶体依赖的方式刺激表皮生长因子受体2(ErbB2)的内化。
J Cell Sci. 2006 Jan 1;119(Pt 1):85-95. doi: 10.1242/jcs.02707. Epub 2005 Dec 13.
7
Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization.在细胞凋亡过程中,半胱天冬酶对表皮生长因子受体的切割与其内化作用无关。
Oncogene. 2006 Mar 9;25(10):1521-31. doi: 10.1038/sj.onc.1209184.
8
The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane.ErbB2对表皮生长因子诱导的网格蛋白包被小窝形成的抑制作用与表皮生长因子受体-ErbB2寡聚复合物在质膜上的滞留相关。
Mol Biol Cell. 2005 Dec;16(12):5832-42. doi: 10.1091/mbc.e05-05-0456. Epub 2005 Oct 5.
9
HSP90 and the chaperoning of cancer.热休克蛋白90与癌症的伴侣蛋白作用
Nat Rev Cancer. 2005 Oct;5(10):761-72. doi: 10.1038/nrc1716.
10
Lysosomes as targets for cancer therapy.溶酶体作为癌症治疗的靶点。
Cancer Res. 2005 Apr 15;65(8):2993-5. doi: 10.1158/0008-5472.CAN-05-0476.